Get the Stockscreener App
51.26
3.66%
-1.95
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Bio Techne Corp stock is traded at $51.26, with a volume of 1.98M.
It is down -3.66% in the last 24 hours and down -2.97% over the past month.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
See More
Previous Close:
$53.21
Open:
$52.96
24h Volume:
1.98M
Relative Volume:
0.92
Market Cap:
$7.97B
Revenue:
$1.17B
Net Income/Loss:
$150.71M
P/E Ratio:
54.53
EPS:
0.94
Net Cash Flow:
$245.03M
1W Performance:
-5.79%
1M Performance:
-2.97%
6M Performance:
-14.90%
1Y Performance:
-29.97%
1-Day Range:
$50.76
$52.96
1-Week Range:
$50.76
$54.62
52-Week Range:
$46.01
$80.95
Bio Techne Corp Stock (TECH) Company Profile
Name
Bio Techne Corp
Sector
Industry
Phone
(612) 379-8854
Address
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Compare TECH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
51.26 | 7.93B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-25 | Upgrade | Citigroup | Neutral → Buy |
| Jul-22-25 | Resumed | Stephens | Overweight |
| Jul-09-25 | Initiated | TD Cowen | Buy |
| May-30-25 | Initiated | Wells Fargo | Overweight |
| Apr-09-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-19-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-24 | Initiated | Scotiabank | Sector Outperform |
| Feb-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-07-23 | Initiated | UBS | Buy |
| Aug-28-23 | Initiated | William Blair | Outperform |
| Jan-10-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Sep-15-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-08-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Feb-23-21 | Upgrade | Stifel | Hold → Buy |
| Jan-25-21 | Reiterated | The Benchmark Company | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Jul-15-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| May-27-20 | Downgrade | Stifel | Buy → Hold |
| May-14-20 | Initiated | The Benchmark Company | Buy |
| Jan-08-20 | Resumed | Stephens | Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-02-19 | Upgrade | Janney | Neutral → Buy |
| Jan-14-19 | Upgrade | Stephens | Equal-Weight → Overweight |
| Oct-31-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-17-18 | Initiated | Goldman | Neutral |
| Jun-15-18 | Initiated | Argus | Buy |
| Jul-13-17 | Initiated | Wells Fargo | Market Perform |
| Feb-09-17 | Initiated | Citigroup | Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Buy |
| Nov-10-16 | Resumed | Leerink Partners | Outperform |
| Jan-21-15 | Reiterated | Robert W. Baird | Outperform |
| Sep-20-13 | Upgrade | Robert W. Baird | Neutral → Outperform |
View All
Bio Techne Corp Stock (TECH) Latest News
MBB Public Markets I LLC Purchases New Stake in Bio-Techne Corp $TECH - MarketBeat
Select Equity Group L.P. Boosts Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Fred Alger Management LLC Has $29.50 Million Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Friday when compared to competitors - MarketWatch
Royal Bank of Canada Sells 93,248 Shares of Bio-Techne Corp $TECH - MarketBeat
Amundi Lowers Position in Bio-Techne Corp $TECH - MarketBeat
NFJ Investment Group LLC Acquires New Position in Bio-Techne Corp $TECH - MarketBeat
Sandler Capital Management Takes $1.58 Million Position in Bio-Techne Corp $TECH - MarketBeat
Curi RMB Capital LLC Lowers Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Polar Asset Management Partners Inc. Sells 13,888 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Shares Sold by Adage Capital Partners GP L.L.C. - MarketBeat
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Why Bio-Techne (TECH) Stock Is Down Today - Yahoo Finance
Bio-Techne at Morgan Stanley Conference: Strategic Insights on Growth and Challenges - Investing.com
Petrus Trust Company LTA Invests $399,000 in Bio-Techne Corp $TECH - MarketBeat
CONMED appoints Bio-Techne CEO Kim Kelderman to board of directors - Investing.com
Bio-Techne CEO and Former Thermo Fisher Executive Kim Kelderman Joins CONMED's Board of Directors - Stock Titan
Bio-Techne at Baird Global Healthcare: Strategic Growth Amid Challenges - Investing.com
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California - Ariva
Bio-Techne (NASDAQ:TECH) Stock Rating Upgraded by Royal Bank Of Canada - MarketBeat
Trexquant Investment LP Makes New $3.75 Million Investment in Bio-Techne Corp $TECH - MarketBeat
Rep. April McClain Delaney Sells Bio-Techne Corp (NASDAQ:TECH) Shares - MarketBeat
Applying big data sentiment scoring on Bio Techne CorporationWeekly Trade Analysis & Safe Swing Trade Setups - Newser
Baird Financial Group Inc. Sells 91,254 Shares of Bio-Techne Corp $TECH - MarketBeat
Rafferty Asset Management LLC Sells 5,894 Shares of Bio-Techne Corp $TECH - MarketBeat
Is Bio Techne Corporation a play on infrastructure spending2025 Key Lessons & Smart Money Movement Alerts - خودرو بانک
Can Bio Techne Corporation outperform in the next rallyWeekly Risk Summary & Real-Time Stock Price Movement Reports - خودرو بانک
Bio-Techne upgraded to Outperform at RBC on strong growth potential - MSN
Market reaction to Bio Techne Corporation’s recent newsJuly 2025 PostEarnings & Safe Entry Trade Reports - Newser
Bio-Techne at Wells Fargo: Navigating Growth Amid Tariff Concerns By Investing.com - Investing.com Australia
Is it time to cut losses on Bio Techne CorporationJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - Newser
Pattern recognition hints at Bio Techne Corporation upside2025 Growth vs Value & High Accuracy Buy Signal Tips - Newser
Understanding Bio Techne Corporation’s price movement2025 Investor Takeaways & Consistent Growth Stock Picks - Newser
Can Bio Techne Corporation benefit from deglobalizationWeekly Profit Summary & Stock Portfolio Risk Control - خودرو بانک
Bio-Techne at Wells Fargo: Navigating Growth Amid Tariff Concerns - Investing.com
Iron Triangle Partners LP Acquires Shares of 250,000 Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Bio-Techne Stock Upgraded As Analyst Flags Attractive Entry Point - Benzinga
Quantitative breakdown of Bio Techne Corporation recent move2025 Earnings Surprises & Safe Swing Trade Setup Alerts - Newser
Candlestick signals on Bio Techne Corporation stock todayMarket Performance Recap & Capital Efficiency Focused Ideas - Newser
Using portfolio simulators with Bio Techne Corporation includedWeekly Risk Report & Capital Efficiency Focused Strategies - Newser
Is Bio Techne Corporation a candidate for recovery playInsider Selling & Precise Buy Zone Tips - Newser
Is Bio Techne Corporation still worth holding after the dip2025 Trade Ideas & Weekly Hot Stock Watchlists - Newser
Is Bio Techne Corporation stock a good dividend stock2025 Winners & Losers & Daily Stock Trend Watchlist - خودرو بانک
Is Bio Techne Corporation stock forming a triangle pattern2025 Breakouts & Breakdowns & AI Forecast Swing Trade Picks - خودرو بانک
Why Bio-Techne (TECH) Shares Are Sliding Today - Yahoo Finance
Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MSN
How high can Bio Techne Corporation stock goMarket Growth Summary & Scalable Portfolio Growth Methods - Newser
What earnings revisions data tells us about Bio Techne CorporationQuarterly Market Summary & Community Consensus Trade Alerts - Newser
Bio Techne Corporation stock outlook for YEARWeekly Loss Report & Weekly High Return Forecasts - Newser
Applying chart zones and confluence areas to Bio Techne CorporationJuly 2025 Analyst Calls & High Accuracy Trade Alerts - Newser
Bio Techne Corp Stock (TECH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):